Market Closed - Nasdaq Stockholm 11:24:19 2024-05-02 EDT 5-day change 1st Jan Change
0.0837 SEK 0.00% Intraday chart for S2Medical AB -16.30% +39.50%

Financials

Sales 2021 10.96M 0 0 Sales 2022 6.16M 0 0 Capitalization 22.09M 0 0
Net income 2021 -20M - - Net income 2022 -29M - - EV / Sales 2021 6.36 x
Net cash position 2021 9.27M 0 0 Net cash position 2022 3.72M 0 0 EV / Sales 2022 2.98 x
P/E ratio 2021
-3.88 x
P/E ratio 2022
-0.55 x
Employees 20
Yield 2021 *
-
Yield 2022
-
Free-Float 59.66%
More Fundamentals * Assessed data
Dynamic Chart
1 week-16.30%
Current month+7.31%
1 month+16.25%
3 months-1.30%
6 months+298.57%
Current year+39.50%
More quotes
1 week
0.08
Extreme 0.079
0.10
1 month
0.07
Extreme 0.0712
0.10
Current year
0.04
Extreme 0.0412
0.15
1 year
0.02
Extreme 0.018
0.86
3 years
0.02
Extreme 0.018
9.25
5 years
0.02
Extreme 0.018
23.80
10 years
0.02
Extreme 0.018
73.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 39 13-06-12
Founder 42 13-06-12
Director of Finance/CFO - -
Members of the board TitleAgeSince
Director/Board Member 63 21-12-31
Founder 42 13-06-12
Chairman 41 19-12-31
More insiders
Date Price Change Volume
24-05-02 0.0837 0.00% 632,276
24-04-30 0.0837 -3.13% 1,858,029
24-04-29 0.0864 -10.74% 2,592,573
24-04-26 0.0968 +1.89% 2,192,150
24-04-25 0.095 +0.32% 2,206,243

Delayed Quote Nasdaq Stockholm, May 02, 2024 at 11:24 am

More quotes
S2Medical AB (publ) is a Sweden-based medical technology company. The Company focuses on developing products for healing burns and chronic wounds, from debridement and granulation to reepithelialization. The Company's product portfolio includes INSTAQRETT, a sterile single-use mechanical debridement tool, the Epiprotect product line based on its collagen-mimicking Eiratex material, which includes EPIPROTECT Safestop, a blood-stilling membrane dressing, EPIPROTECT 2117, a synthetic substitute to allografts and xenografts, EPIPROTECT ULCER, dressing for treating ulcers, as well as INSTABIND bandages and Instagraft, a single-use medical device designed to treat chronic wounds with microtransplants from the patient's own skin without creating any new wounds. The Company is also the official distributor of Silverlon antimicrobial dressings for Nordic countries. In addition, it operates the S2Clinic, a wound healing center in Sweden.
More about the company